EXPLAINING INTERPATIENT VARIABILITY OF ADALIMUMAB RESPONSE IN CHRONIC PLAQUE PSORIASIS BY PHARMACOKINETIC-PHARMACODYNAMIC MODELING: RESULTS FROM THE OPTIMAP STUDY.

Bank, P; van Huizen, A; Spuls, P; Mathot, R

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023; 113 (): S95